Japanese Pharma Company Takeda Expects Limited Exposure To US-China Tariffs

Takeda Pharmaceutical Company Limited (NYSE:TAK) reported a fiscal twelvemonth 2024 nett net of 107.9 cardinal yen (around $709.86 million), down 25.1% twelvemonth implicit year.
Core nett net accrued 2.5% (down 3.4% astatine changeless currency) to 775.6 cardinal yen.
Takeda CEO Christophe Weber said, "Takeda…

This communicative appeared connected benzinga.com, 2025-05-08 14:32:03.